Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 13%
Buy 38%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Holdings Inc. reported a revenue rate of $495.43, reflecting a slight increase of 0.6%, alongside an improved gross margin of 32.6%, which surpassed expectations due to better-than-anticipated brand and regional administrative costs. The company demonstrated substantial growth in its Private Duty Services and Home Health & Hospice segments, with PDS revenue at $514.4 million, marking a remarkable 25.6% year-on-year increase, and HHH revenue reaching $62.4 million, a 15.3% growth compared to the previous year. Additionally, Aveanna's cash flow performance improved, enhancing its financial flexibility, as management raised revenue guidance to over $2.375 billion, signaling confidence in continued growth driven by operational execution and strategic integration efforts.

Bears say

Aveanna Healthcare Holdings Inc faces numerous challenges that contribute to a negative outlook. Key concerns include potential reimbursement pressures, high leverage, and an inability to effectively integrate acquisitions, which could hinder growth and profitability. Additionally, projected labor headwinds may lead to a significant downside in adjusted EBITDA estimates for FY26, and there are ongoing risks related to regulatory issues and increasing competition in the healthcare market.

AVAH has been analyzed by 8 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 38% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 8 analysts, AVAH has a Buy consensus rating as of Mar 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.56, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.56, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.